Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
11(84.6%)
Phase 4
2(15.4%)
13Total
N/A(11)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT05042505Not ApplicableCompleted

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

Role: lead

NCT06289387Completed

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes

Role: lead

NCT06035874Not ApplicableRecruiting

Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

Role: lead

NCT06187285Not ApplicableCompleted

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Role: lead

NCT06060392Not ApplicableRecruiting

Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus

Role: lead

NCT05548114Not ApplicableActive Not Recruiting

Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction

Role: collaborator

NCT05036876Not ApplicableCompleted

Degludec Glargine U300 Hospital Study

Role: lead

NCT06095492Not ApplicableRecruiting

Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus

Role: lead

NCT06098625Not ApplicableUnknown

Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus

Role: lead

NCT05457933Phase 4Completed

Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

Role: lead

NCT02443389Completed

Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates

Role: collaborator

NCT04286399Phase 4Recruiting

Asian Diabetes Outcomes Prevention Trial

Role: collaborator

NCT03590626Not ApplicableCompleted

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Role: lead

NCT02686476Not ApplicableCompleted

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes

Role: lead

NCT02040103Not ApplicableCompleted

Pneumatic Compression for Preventing Venous Thromboembolism

Role: collaborator

NCT01706640Unknown

An Open Label,Observational, Real Time Data Capturing of Usage & Outcome of Coseal

Role: lead

All 16 trials loaded